{
  "context": {
    "rules": [
      "Rule1: Whenever drug development requires FDA approval, compound discovers therapeutic.",
      "Rule2: Either drug development requires FDA approval or drug development requires clinical trial.",
      "Rule3: If drug is rejected by FDA, then it is not the case that drug is approved for market.",
      "Rule4: Either drug is rejected by FDA or drug is recalled from market.",
      "Rule5: Either drug is banned in country, or if drug is contraindicated for patients, then drug is not prescribed by doctors.",
      "Rule6: Supplier meets GMP standards or supplier fails audit.",
      "Rule7: If supplier fails audit, then company is profitable in business.",
      "Rule8: Whenever drug development requires clinical trial, company is profitable in business.",
      "Rule9: Provided raw material passes purity test, then if raw material requires certificate and it is not the case that whenever supplier meets GMP standards then company is profitable in business leads to supplier not qualifying for contract, then supplier is disqualified from bidding.",
      "Rule10: Either raw material passes purity test or raw material fails impurity test.",
      "Rule11: If raw material fails impurity test, then provided raw material requires certificate and under the condition that it is not true that supplier meeting GMP standards implies company profitability leads to supplier not qualifying for contract, then supplier is disqualified from bidding.",
      "Rule12: In case manufacturing requires clean room, company is profitable in business.",
      "Rule13: Either maintenance schedules preventive, or if equipment reports malfunction and provided it is not the case that manufacturing not requiring clean room leads to manufacturing not requiring sterilization, then production halts line.",
      "Rule14: Formulation containing active ingredient implies formulation contains excipient.",
      "Rule15: Under the condition that batch exceeds yield target, batch does not meet quality standards.",
      "Rule16: Either batch exceeds yield target or production does not accelerate timeline.",
      "Rule17: If batch passes release test, then whenever batch exceeds yield target, batch meets quality standards.",
      "Rule18: Batch passes release test or batch fails potency test.",
      "Rule19: In case batch fails potency test, then if batch exceeds yield target, batch meets quality standards.",
      "Rule20: Given drug completes development, company is profitable in business.",
      "Rule21: If drug files patent, then drug completes development.",
      "Rule22: Whenever compound discovers therapeutic, compound synthesizes in laboratory.",
      "Rule23: Formulation containing excipient implies formulation contains stabilizer.",
      "Rule24: If formulation contains excipient, then drug scales production.",
      "Rule25: Either raw material imports internationally, or if compound synthesizes in laboratory, then drug files patent.",
      "Rule26: Supplier complying with regulations implies raw material does not import internationally.",
      "Rule27: If supplier is certified for ISO, then supplier complies with regulations.",
      "Rule28: Supplier is certified for ISO or supplier is accredited by FDA.",
      "Rule29: Provided supplier is accredited by FDA, supplier complies with regulations.",
      "Rule30: In case formulation maintains stability, then whenever drug development requires FDA approval, company is profitable in business.",
      "Rule31: Under the condition that formulation adds preservative, formulation controls pH level.",
      "Rule32: Either formulation tests compatibility or formulation validates method.",
      "Rule33: In case formulation validates method, then if formulation controls pH level, formulation maintains stability.",
      "Rule34: Under the condition that formulation contains stabilizer, formulation adds preservative.",
      "Rule35: Whenever drug develops formulation, then if drug development requires FDA approval, company is profitable in business.",
      "Rule36: Provided drug optimizes dosage, drug develops formulation.",
      "Rule37: If drug scales production, then drug optimizes dosage.",
      "Rule38: In case intellectual property protects by patent, patent files application.",
      "Rule39: Provided patent grants protection, then if patent files application, patent does not infringe rights.",
      "Rule40: If patent registers at office, then patent grants protection.",
      "Rule41: Whenever patent challenges validity, generic is not approved by FDA.",
      "Rule42: Either patent challenges validity or patent licenses to generic.",
      "Rule43: If patent violates law, then dispute settles in court.",
      "Rule44: Either patent violates law, or if patent licenses to generic, generic is not approved by FDA.",
      "Rule45: Under the condition that company pays damages, company loses case.",
      "Rule46: Provided facility operates under GMP, facility upgrades equipment.",
      "Rule47: In case facility operates under GMP, facility does not pass inspection.",
      "Rule48: Either facility operates under GMP or manufacturing requires clean room.",
      "Rule49: Whenever batch fails quality check, then if it is not true that formulation containing stabilizer implies that drug development requiring FDA approval leads to company profitability, then formulation does not pass stability test.",
      "Rule50: Either batch fails quality check or batch fails contamination test.",
      "Rule51: Under the condition that facility maintains compliance, then if facility upgrades equipment, facility passes inspection.",
      "Rule52: If staff trains in procedures, then system implements quality.",
      "Rule53: Either staff trains in procedures or processes document properly.",
      "Rule54: In case processes document properly, facility maintains compliance.",
      "Rule55: Provided system implements quality, system reviews regularly.",
      "Rule56: If system reviews regularly, then facility maintains compliance.",
      "Rule57: Under the condition that batch fails contamination test, then if it is not the case that formulation containing stabilizer implies that drug development requiring FDA approval leads to company profitability, then formulation does not pass stability test.",
      "Rule58: Either drug is approved for market or company is profitable in business.",
      "Rule59: If it is not the case that drug recalled from market implies drug not approved for market, then generic is approved for market.",
      "Rule60: Provided it is not true that drug recalled from market leads to drug not approved for market, generic is approved by FDA.",
      "Rule61: Whenever it is not true that supplier meeting GMP standards leads to company profitability, supplier qualifies for contract.",
      "Rule62: Provided it is not the case that formulation testing compatibility implies that formulation controlling pH level leads to formulation maintaining stability, formulation approves specification.",
      "Rule63: If it is not true that formulation tests compatibility implies that formulation controls pH level and formulation maintains stability, then formulation does not approve specification.",
      "Rule64: Whenever it is not the case that formulation containing stabilizer implies that drug development requiring FDA approval leads to company profitability, formulation passes stability test.",
      "Rule65: Provided it is not the case that dispute settling in court implies company facing lawsuit, company pays damages.",
      "Rule66: If it is not true that whenever drug recalled from market implies drug not approved for market leads to generic not approved for market, then biosimilar is approved for market.",
      "Rule67: Provided it is not the case that supplier meets GMP standards and company is profitable in business implies supplier does not qualify for contract, then supplier is not disqualified from bidding.",
      "Rule68: If it is not true that formulation containing excipient implying drug development requiring FDA approval and company profitability leads to production delaying schedule, production accelerates timeline.",
      "Rule69: Whenever it is not the case that drug recalled from market implying drug not approved for market leading to generic not approved for market implies technology licensing to partner, patent infringes rights.",
      "Rule70: Under the condition that it is not the case that company not profitable in business implies drug not available to patients, drug is prescribed by doctors.",
      "Rule71: If it is not true that company not being profitable in business leads to drug not available to patients, then drug is contraindicated for patients.",
      "Rule72: Whenever manufacturing does not require clean room, manufacturing requires sterilization.",
      "Rule73: If company is not profitable in business, drug is available to patients."
    ],
    "facts": [
      "Fact1: Raw material requires certificate.",
      "Fact2: Equipment reports malfunction.",
      "Fact3: Formulation contains active ingredient.",
      "Fact4: Intellectual property protects by patent.",
      "Fact5: Patent registers at office.",
      "Fact6: It is not the case that biosimilar is approved for market.",
      "Fact7: Drug is not banned in country.",
      "Fact8: Production does not halt line.",
      "Fact9: Maintenance does not schedule preventive.",
      "Fact10: Production does not delay schedule.",
      "Fact11: Technology does not license to partner.",
      "Fact12: Company does not face lawsuit.",
      "Fact13: Company does not lose case."
    ]
  },
  "question": "Company is profitable in business."
}